Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Vasculitis
•
General Rheumatology
•
Pharmacology
How do you use mesna in your patients who are being started on cyclophosphamide?
Related Questions
Would you use a reduced dose glucocorticoid tapering regimen for patients with vasculitis due to Sjögren’s syndrome treated with Rituximab?
How would you approach management of incidentally identified unilateral retinal vasculitis with subsequent labs revealing +P-ANCA?
How would you approach evaluation of a patient with multiple vertebral artery pseudoaneurysms and history of dissection, but without other areas of pseudoaneurysms?
What would be the preferred treatment option for PMR if patient develops gastric perforation soon after initiation of steroids?
What else do you consider in the differential diagnosis for pulmonary-renal syndromes if there is low clinical and serologic evidence of AAV, Goodpasture's or other rheumatologic disease (SLE, RA, APS, Scleroderma)?
How do you approach the work up of pulmonary artery aneurysm in the absence of other clinical features of Behcet’s?
Would you continue Rituximab infusions in a patient with GPA and renal involvement who has been in remission on Avacopan and Rituximab, but had PRES post Rituximab infusion?
What baseline and ongoing testing do you recommend for patients with PMR who are going to be on a prolonged steroid taper?
What is your approach to evaluation and management of a patient with Blau Syndrome and GI manifestations?
How do you approach evaluation for indolent infection in patients with chronic erosive arthropathy?
